As of 2025-02-13, the Relative Valuation of Integra Lifesciences Holdings Corp (IART) is 16.83 USD. This relative valuation is based on P/E multiples. With the latest stock price at 24.08 USD, the upside of Integra Lifesciences Holdings Corp based on Relative Valuation is -30.1%.
The range of the Relative Valuation is (1.92) - 39.18 USD.
Range | Selected | |
Trailing P/E multiples | 22.6x - 38.6x | 34.4x |
Forward P/E multiples | 25.8x - 31.6x | 29.5x |
Fair Price | (1.92) - 39.18 | 16.83 |
Upside | -108.0% - 62.7% | -30.1% |
Date | P/E |
2025-02-07 | -297.37 |
2025-02-06 | -306.80 |
2025-02-05 | -313.05 |
2025-02-04 | -307.15 |
2025-02-03 | -306.56 |
2025-01-31 | -307.74 |
2025-01-30 | -310.57 |
2025-01-29 | -307.98 |
2025-01-28 | -306.68 |
2025-01-27 | -310.93 |
2025-01-24 | -307.15 |
2025-01-23 | -301.85 |
2025-01-22 | -293.01 |
2025-01-21 | -296.19 |
2025-01-17 | -284.16 |
2025-01-16 | -274.02 |
2025-01-15 | -264.35 |
2025-01-14 | -258.58 |
2025-01-13 | -262.82 |
2025-01-10 | -257.16 |
2025-01-08 | -262.35 |
2025-01-07 | -261.17 |
2025-01-06 | -255.86 |
2025-01-03 | -273.20 |
2025-01-02 | -271.43 |
2024-12-31 | -267.42 |
2024-12-30 | -264.94 |
2024-12-27 | -263.29 |
2024-12-26 | -267.65 |
2024-12-24 | -260.93 |
2024-12-23 | -259.52 |
2024-12-20 | -257.04 |
2024-12-19 | -255.98 |
2024-12-18 | -261.29 |
2024-12-17 | -271.55 |
2024-12-16 | -279.56 |
2024-12-13 | -283.34 |
2024-12-12 | -285.81 |
2024-12-11 | -284.75 |
2024-12-10 | -283.10 |
2024-12-09 | -287.46 |
2024-12-06 | -284.16 |
2024-12-05 | -281.33 |
2024-12-04 | -284.28 |
2024-12-03 | -290.41 |
2024-12-02 | -289.82 |
2024-11-29 | -289.82 |
2024-11-27 | -289.35 |
2024-11-26 | -279.45 |
2024-11-25 | -285.81 |